A new code will be discussed at a special CPT Editorial Panel meeting during the week of March 9. The panel plans to decide on a code and its effective date.
“Moving as quickly as possible to put in place a CPT code for a novel coronavirus test will bolster a data-driven response to the COVID-19 disease outbreak in the United States,” AMA President Patrice Harris, MD, said in a prepared statement March 10. “By streamlining the flow of information on novel coronavirus testing, a new CPT code facilitates the reporting, measuring, analyzing, researching, and benchmarking that is necessary to help guide the nation’s response to the public health emergency.”
CMS has released two codes for tests related to COVID-19, set to take effect April 1 for dates of services Feb. 4 onward: U0001 for the CDC’s test and U0002 for commercial testing.
More articles on healthcare finance:
North Carolina health system files for bankruptcy
14 health systems with strong finances
Physician-owned hospital in Ohio closes
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
